StonvexLoading…
StonvexStonvexStonvexCore line items from HYFM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.25M | $190.29M | $226.58M | $344.50M |
Operating Income | $-276.92M | $-52.18M | $-49.70M | $-281.60M |
Net Income | $-289.79M | $-66.72M | $-64.81M | $-285.42M |
EPS (Diluted) | $-62.35 | $-14.51 | $-14.24 | $-6.35 |
Total Assets | $123.80M | $426.10M | $507.64M | $573.56M |
Total Liabilities | $187.10M | $202.38M | $217.03M | $223.68M |
Cash & Equivalents | $6.31M | $26.11M | $30.31M | $21.29M |
Free Cash Flow OCF − CapEx | $-15.08M | $-3.22M | $2.83M | $13.76M |
Shares Outstanding | 4.67M | 4.61M | 4.58M | 45.20M |